Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 13 | 2025 | 85 | 3.070 |
Why?
|
| Contraceptive Agents, Female | 5 | 2022 | 32 | 1.820 |
Why?
|
| Abortion, Legal | 5 | 2026 | 18 | 1.420 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2022 | 21 | 1.290 |
Why?
|
| Travel | 3 | 2024 | 129 | 0.940 |
Why?
|
| Contraception | 4 | 2023 | 62 | 0.900 |
Why?
|
| Governing Board | 1 | 2024 | 3 | 0.870 |
Why?
|
| Maternal Health Services | 1 | 2024 | 46 | 0.830 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2022 | 167 | 0.740 |
Why?
|
| Health Services Accessibility | 8 | 2025 | 701 | 0.720 |
Why?
|
| Pregnancy | 20 | 2026 | 7577 | 0.690 |
Why?
|
| Pregnancy Complications | 2 | 2024 | 547 | 0.620 |
Why?
|
| Gynecology | 3 | 2026 | 129 | 0.580 |
Why?
|
| Delivery of Health Care | 1 | 2024 | 683 | 0.550 |
Why?
|
| Obstetrics | 3 | 2026 | 246 | 0.530 |
Why?
|
| Ambulatory Care Facilities | 3 | 2020 | 236 | 0.520 |
Why?
|
| Texas | 12 | 2025 | 3629 | 0.470 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 2011 | 16 | 0.440 |
Why?
|
| Reproductive Health Services | 1 | 2013 | 24 | 0.410 |
Why?
|
| Patient Preference | 2 | 2025 | 146 | 0.400 |
Why?
|
| Family Planning Services | 2 | 2023 | 39 | 0.380 |
Why?
|
| Ethinyl Estradiol | 1 | 2011 | 11 | 0.360 |
Why?
|
| Levonorgestrel | 1 | 2011 | 20 | 0.360 |
Why?
|
| Carbohydrate Metabolism | 1 | 2011 | 51 | 0.350 |
Why?
|
| Injections, Subcutaneous | 3 | 2022 | 134 | 0.320 |
Why?
|
| Female | 26 | 2026 | 71316 | 0.300 |
Why?
|
| Pregnancy in Adolescence | 1 | 2009 | 53 | 0.300 |
Why?
|
| Misoprostol | 3 | 2025 | 25 | 0.290 |
Why?
|
| Confidentiality | 1 | 2009 | 104 | 0.290 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 372 | 0.290 |
Why?
|
| Students, Medical | 2 | 2022 | 350 | 0.260 |
Why?
|
| State Government | 1 | 2026 | 30 | 0.240 |
Why?
|
| Abortifacient Agents | 2 | 2020 | 3 | 0.240 |
Why?
|
| Abortion Applicants | 1 | 2025 | 2 | 0.240 |
Why?
|
| Humans | 29 | 2026 | 131967 | 0.230 |
Why?
|
| United States | 12 | 2026 | 11827 | 0.230 |
Why?
|
| Drug Implants | 3 | 2020 | 41 | 0.220 |
Why?
|
| Medical Futility | 1 | 2024 | 41 | 0.210 |
Why?
|
| Travel-Related Illness | 1 | 2023 | 8 | 0.200 |
Why?
|
| Maternal Mortality | 1 | 2024 | 81 | 0.200 |
Why?
|
| Choice Behavior | 1 | 2024 | 132 | 0.200 |
Why?
|
| Abortifacient Agents, Steroidal | 1 | 2023 | 1 | 0.200 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2023 | 3 | 0.200 |
Why?
|
| Internship and Residency | 2 | 2024 | 1217 | 0.200 |
Why?
|
| Intrauterine Devices | 2 | 2013 | 14 | 0.180 |
Why?
|
| Analgesia | 1 | 2021 | 43 | 0.170 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 84 | 0.170 |
Why?
|
| Quality of Health Care | 1 | 2024 | 411 | 0.170 |
Why?
|
| Young Adult | 7 | 2025 | 10108 | 0.170 |
Why?
|
| Medicaid | 1 | 2023 | 252 | 0.170 |
Why?
|
| Desogestrel | 1 | 2020 | 7 | 0.160 |
Why?
|
| Adult | 10 | 2025 | 31734 | 0.160 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 4058 | 0.160 |
Why?
|
| Obesity | 1 | 2011 | 2392 | 0.160 |
Why?
|
| Health Policy | 1 | 2022 | 227 | 0.160 |
Why?
|
| Anesthesia | 1 | 2021 | 209 | 0.150 |
Why?
|
| Self Administration | 2 | 2017 | 49 | 0.140 |
Why?
|
| Decision Making | 1 | 2023 | 687 | 0.140 |
Why?
|
| Education, Medical | 1 | 2022 | 287 | 0.140 |
Why?
|
| Contraception Behavior | 1 | 2017 | 29 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 180 | 0.130 |
Why?
|
| Intuition | 1 | 2017 | 5 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 424 | 0.120 |
Why?
|
| Physicians | 1 | 2023 | 634 | 0.120 |
Why?
|
| Delayed-Action Preparations | 2 | 2017 | 121 | 0.110 |
Why?
|
| Feeding Behavior | 2 | 2020 | 724 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2017 | 838 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 502 | 0.110 |
Why?
|
| Eating | 1 | 2017 | 382 | 0.110 |
Why?
|
| Adolescent | 6 | 2025 | 21008 | 0.110 |
Why?
|
| Postpartum Period | 2 | 2020 | 236 | 0.100 |
Why?
|
| Body Mass Index | 3 | 2020 | 1695 | 0.100 |
Why?
|
| Office Visits | 1 | 2013 | 81 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2013 | 140 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2013 | 134 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1396 | 0.090 |
Why?
|
| Mifepristone | 2 | 2023 | 89 | 0.090 |
Why?
|
| Patient Dropouts | 1 | 2011 | 50 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2011 | 280 | 0.080 |
Why?
|
| Contraception, Barrier | 1 | 2010 | 1 | 0.080 |
Why?
|
| Sterilization, Reproductive | 1 | 2010 | 6 | 0.080 |
Why?
|
| Perimenopause | 1 | 2010 | 3 | 0.080 |
Why?
|
| Progestins | 1 | 2010 | 42 | 0.080 |
Why?
|
| Contraceptives, Oral | 1 | 2010 | 40 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 394 | 0.080 |
Why?
|
| Diet | 1 | 2017 | 1118 | 0.080 |
Why?
|
| Vacuum Curettage | 1 | 2009 | 4 | 0.080 |
Why?
|
| Patient Selection | 1 | 2013 | 726 | 0.080 |
Why?
|
| Dilatation and Curettage | 1 | 2009 | 8 | 0.070 |
Why?
|
| Gestational Trophoblastic Disease | 1 | 2009 | 10 | 0.070 |
Why?
|
| Triglycerides | 1 | 2011 | 605 | 0.070 |
Why?
|
| Uterine Hemorrhage | 1 | 2009 | 42 | 0.070 |
Why?
|
| Incidence | 2 | 2022 | 3352 | 0.070 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 49 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2011 | 334 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 612 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1626 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2011 | 1638 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2009 | 256 | 0.070 |
Why?
|
| Catheterization | 1 | 2009 | 234 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2011 | 1104 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2010 | 469 | 0.060 |
Why?
|
| Informed Consent | 1 | 2009 | 343 | 0.060 |
Why?
|
| Insulin | 1 | 2011 | 1154 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2011 | 683 | 0.060 |
Why?
|
| Attitude of Health Personnel | 2 | 2022 | 721 | 0.060 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 423 | 0.060 |
Why?
|
| Age Factors | 1 | 2010 | 2869 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 307 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2022 | 26 | 0.050 |
Why?
|
| Government Regulation | 1 | 2022 | 44 | 0.050 |
Why?
|
| Biomarkers | 1 | 2011 | 3415 | 0.040 |
Why?
|
| Perinatology | 1 | 2021 | 36 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 1357 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 122 | 0.040 |
Why?
|
| Counseling | 1 | 2023 | 237 | 0.040 |
Why?
|
| Forecasting | 1 | 2022 | 361 | 0.040 |
Why?
|
| Geographic Mapping | 1 | 2020 | 15 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 50 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 445 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2020 | 52 | 0.040 |
Why?
|
| Spatial Analysis | 1 | 2020 | 28 | 0.040 |
Why?
|
| Drug Labeling | 1 | 2020 | 29 | 0.040 |
Why?
|
| Pain Management | 1 | 2021 | 203 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 157 | 0.040 |
Why?
|
| Telemedicine | 1 | 2025 | 524 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 439 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 1545 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 17703 | 0.040 |
Why?
|
| International Planned Parenthood Federation | 1 | 2017 | 1 | 0.030 |
Why?
|
| New Jersey | 1 | 2017 | 26 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 548 | 0.030 |
Why?
|
| Rural Population | 1 | 2020 | 260 | 0.030 |
Why?
|
| Satiety Response | 1 | 2017 | 31 | 0.030 |
Why?
|
| Overweight | 1 | 2020 | 378 | 0.030 |
Why?
|
| Hunger | 1 | 2017 | 43 | 0.030 |
Why?
|
| Cues | 1 | 2017 | 98 | 0.030 |
Why?
|
| Poverty | 1 | 2020 | 456 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 235 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1235 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1838 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1224 | 0.030 |
Why?
|
| Weight Gain | 1 | 2017 | 384 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 460 | 0.030 |
Why?
|
| Emotions | 1 | 2017 | 367 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 678 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 990 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2992 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2009 | 48 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6522 | 0.020 |
Why?
|
| Leucovorin | 1 | 2009 | 54 | 0.020 |
Why?
|
| Etoposide | 1 | 2009 | 117 | 0.020 |
Why?
|
| Depression | 1 | 2017 | 1352 | 0.020 |
Why?
|
| Methotrexate | 1 | 2009 | 344 | 0.020 |
Why?
|
| Male | 1 | 2024 | 65357 | 0.010 |
Why?
|